(Q47807119)

English

Bevacizumab in hereditary hemorrhagic telangiectasia

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19439755

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/19439755

title

Bevacizumab in hereditary hemorrhagic telangiectasia (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19439755

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/19439755

main subject

hereditary hemorrhagic telangiectasia

0 references

1 reference

Prithviraj Bose

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19439755

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/19439755

Jennifer L Holter

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19439755

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/19439755

George B Selby

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19439755

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/19439755

language of work or name

English

0 references

publication date

1 May 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19439755

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/19439755

published in

The New England Journal of Medicine

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19439755

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/19439755

volume

360

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19439755

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/19439755

issue

20

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19439755

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/19439755

page(s)

2143-2144

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19439755

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/19439755

Identifiers

DOI

10.1056/NEJMC0901421

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19439755

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/19439755

Fatcat ID

release_osu4oefgojcpdb6y3l236vuqfy

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/osu4oefgojcpdb6y3l236vuqfy

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

19439755

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19439755

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/19439755

(Q47807119)

Bevacizumab in hereditary hemorrhagic telangiectasia

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)